Facebook Billionaire Investing in a Shocking New Industry

From Investing Trends | Ad

Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.

And today, you could get in on the ground floor

STRO Insider Trading (Sutro Biopharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $14,593,701.37

Sutro Biopharma Insider Trading History Chart

Sutro Biopharma Share Price & Price History

^$19.92

▲ +1.19 (6.35%)

As of 06/18/2021 01:00 AM ET

Days: 30 | 90 | 365

Facebook Billionaire Investing in a Shocking New Industry

From Investing Trends | Ad

Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.

And today, you could get in on the ground floor

Sutro Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/26/2021	Trevor Hallam	Insider	Sell	2,393	$25.71	$61,524.03	58,510
12/28/2020	Trevor Hallam	Insider	Sell	2,393	$22.37	$53,531.41	39,105
11/27/2020	Trevor Hallam	Insider	Sell	2,393	$17.01	$40,704.93	39,105
11/5/2020	Trevor Hallam	Insider	Sell	16,751	$15.00	$251,265.00	53,463
9/28/2020	Trevor Hallam	Insider	Sell	975	$10.26	$10,003.50	27,809
9/18/2020	John Gordon Freund	Director	Sell	400,000	$12.00	$4,800,000.00
9/11/2020	John Gordon Freund	Director	Sell	500,000	$10.00	$5,000,000.00
8/26/2020	Trevor Hallam	Insider	Sell	975	$9.04	$8,814.00	16,790
8/19/2020	John Gordon Freund	Director	Sell	500,000	$8.72	$4,360,000.00
7/27/2020	Trevor Hallam	Insider	Sell	975	$8.06	$7,858.50	17,765
5/26/2020	Trevor Hallam	Insider	Sell	975	$10.00	$9,750.00	19,715
5/14/2020	Arturo Md Molina	Insider	Buy	6,451	$7.75	$49,995.25	12,083
5/14/2020	William J Newell	CEO	Buy	64,516	$7.75	$499,999.00	166,627
4/27/2020	Trevor Hallam	Insider	Sell	975	$9.42	$9,184.50	20,692
3/26/2020	Trevor Hallam	Insider	Sell	975	$9.69	$9,447.75	21,665
2/26/2020	Trevor Hallam	Insider	Sell	975	$10.47	$10,208.25	22,640
1/27/2020	Trevor Hallam	Insider	Sell	975	$10.51	$10,247.25	23,615
11/26/2019	Trevor Hallam	Insider	Sell	975	$10.68	$10,413.00	25,565
10/1/2018	Daniel H Petree	Director	Sell	122	$15.00	$1,830.00
10/1/2018	Merck & Co., Inc.	Major Shareholder	Buy	666,666	$15.00	$9,999,990.00

SEC Filings (Institutional Ownership Changes) for Sutro Biopharma (NASDAQ:STRO)

96.20% of Sutro Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Sutro Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2021	BVF Inc. IL	826,825	$18.82M	0.7%	-55.4%	1.793%
5/18/2021	Opaleye Management Inc.	341,950	$7.78M	1.1%	+6.1%	0.742%
5/18/2021	First Light Asset Management LLC	2,058,447	$46.85M	3.1%	+148.9%	4.464%
5/18/2021	Point72 Asset Management L.P.	958,200	$21.81M	0.1%	-32.0%	2.078%
5/18/2021	D. E. Shaw & Co. Inc.	42,606	$0.97M	0.0%	-56.8%	0.092%
5/18/2021	Verition Fund Management LLC	471,332	$10.73M	0.1%	+44.7%	1.022%
5/18/2021	Loomis Sayles & Co. L P	1,354,993	$30.84M	0.0%	N/A	2.938%
5/18/2021	Morgan Stanley	773,106	$17.60M	0.0%	+487.4%	1.677%
5/18/2021	Cubist Systematic Strategies LLC	39,160	$0.89M	0.0%	+137.4%	0.085%
5/18/2021	Holocene Advisors LP	1,423,205	$32.39M	0.2%	+33.4%	3.086%
5/18/2021	Pentwater Capital Management LP	184,501	$4.20M	0.0%	-35.1%	0.400%
5/18/2021	Jane Street Group LLC	22,404	$0.51M	0.0%	N/A	0.049%
5/18/2021	California State Teachers Retirement System	49,024	$1.12M	0.0%	+16.2%	0.106%
5/17/2021	Schonfeld Strategic Advisors LLC	71,614	$1.63M	0.0%	-47.8%	0.155%
5/17/2021	AQR Capital Management LLC	42,670	$0.97M	0.0%	+184.3%	0.093%
5/17/2021	Royal Bank of Canada	2,716	$62K	0.0%	+462.3%	0.006%
5/17/2021	Suvretta Capital Management LLC	1,284,976	$29.25M	0.4%	+24.1%	2.787%
5/17/2021	Woodline Partners LP	215,974	$4.92M	0.1%	+18.6%	0.468%
5/17/2021	Janus Henderson Group PLC	162,472	$3.70M	0.0%	-11.2%	0.352%
5/17/2021	Nuveen Asset Management LLC	385,228	$8.77M	0.0%	+45.7%	0.835%
5/17/2021	Sphera Funds Management LTD.	294,825	$6.71M	0.5%	+46.2%	0.639%
5/17/2021	Goldman Sachs Group Inc.	73,393	$1.67M	0.0%	-44.8%	0.159%
5/14/2021	Kennedy Capital Management Inc.	141,290	$3.22M	0.1%	-6.0%	0.306%
5/14/2021	Arrowstreet Capital Limited Partnership	27,300	$0.62M	0.0%	N/A	0.059%
5/14/2021	FIL Ltd	771,790	$17.57M	0.0%	+3.7%	1.674%
5/14/2021	Dimensional Fund Advisors LP	362,177	$8.23M	0.0%	+267.5%	0.785%
5/14/2021	Tekla Capital Management LLC	573,823	$13.06M	0.4%	-18.3%	1.244%
5/14/2021	Parkman Healthcare Partners LLC	202,696	$4.61M	1.1%	-24.0%	0.440%
5/14/2021	Algert Global LLC	45,790	$1.04M	0.3%	-28.7%	0.099%
5/13/2021	Franklin Resources Inc.	2,646,804	$60.24M	0.0%	+18.9%	5.740%
5/13/2021	SG Americas Securities LLC	6,841	$0.16M	0.0%	N/A	0.015%
5/13/2021	Barclays PLC	260,123	$5.92M	0.0%	+13.0%	0.564%
5/13/2021	Neuberger Berman Group LLC	212,209	$4.83M	0.0%	+74.7%	0.460%
5/13/2021	Bank of New York Mellon Corp	101,398	$2.31M	0.0%	+0.6%	0.220%
5/13/2021	Citigroup Inc.	169,594	$3.86M	0.0%	+239.4%	0.368%
5/13/2021	Federated Hermes Inc.	328,774	$7.48M	0.0%	+149.5%	0.713%
5/12/2021	Northern Trust Corp	344,321	$7.84M	0.0%	+9.6%	0.747%
5/12/2021	Geode Capital Management LLC	566,649	$12.90M	0.0%	+35.4%	1.229%
5/12/2021	Financial Engines Advisors L.L.C.	10,151	$0.23M	0.0%	N/A	0.022%
5/12/2021	JPMorgan Chase & Co.	59,087	$1.35M	0.0%	-11.3%	0.128%
5/12/2021	Panagora Asset Management Inc.	67,265	$1.53M	0.0%	+2.8%	0.146%
5/12/2021	E Fund Management Co. Ltd.	5,714	$0.13M	0.0%	N/A	0.012%
5/11/2021	Acadian Asset Management LLC	237,393	$5.40M	0.0%	+97.6%	0.515%
5/11/2021	EAM Global Investors LLC	74,142	$1.69M	0.5%	-38.6%	0.161%
5/11/2021	EAM Investors LLC	52,643	$1.20M	0.2%	-38.4%	0.114%
5/10/2021	Russell Investments Group Ltd.	55,534	$1.26M	0.0%	+8.4%	0.120%
5/10/2021	State Board of Administration of Florida Retirement System	8,790	$0.20M	0.0%	N/A	0.019%
5/10/2021	Rafferty Asset Management LLC	137,303	$3.13M	0.0%	N/A	0.298%
5/7/2021	BlackRock Inc.	3,101,973	$70.60M	0.0%	+14.1%	6.728%
5/7/2021	American International Group Inc.	18,943	$0.43M	0.0%	+16.9%	0.041%
5/7/2021	BNP Paribas Arbitrage SA	28,054	$0.64M	0.0%	+356.8%	0.061%
5/6/2021	Rhumbline Advisers	29,251	$0.67M	0.0%	+5.6%	0.063%
5/6/2021	Alliancebernstein L.P.	88,824	$2.02M	0.0%	+458.6%	0.193%
5/6/2021	Altium Capital Management LP	226,719	$5.16M	1.4%	-18.1%	0.492%
5/3/2021	The Manufacturers Life Insurance Company	18,833	$0.43M	0.0%	+9.3%	0.041%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	2,572	$59K	0.0%	N/A	0.006%
4/28/2021	Meeder Asset Management Inc.	1,624	$37K	0.0%	N/A	0.004%
4/27/2021	First Quadrant L P CA	6,000	$0.14M	0.0%	-14.2%	0.013%
4/27/2021	Dorsey Wright & Associates	1,832	$42K	0.5%	+135.2%	0.004%
4/23/2021	Compagnie Lombard Odier SCmA	290,418	$6.61M	0.1%	N/A	0.633%
4/22/2021	HighMark Wealth Management LLC	1,285	$29K	0.0%	+87.3%	0.003%
4/5/2021	Pacer Advisors Inc.	3,216	$73K	0.0%	N/A	0.007%
3/12/2021	DekaBank Deutsche Girozentrale	11,000	$0.23M	0.0%	N/A	0.028%
3/8/2021	Dimensional Fund Advisors LP	98,551	$2.14M	0.0%	N/A	0.255%
2/25/2021	Dimensional Fund Advisors LP	98,551	$2.14M	0.0%	N/A	0.255%
2/19/2021	JPMorgan Chase & Co.	66,597	$1.45M	0.0%	-8.0%	0.173%
2/18/2021	Verition Fund Management LLC	325,765	$7.07M	0.1%	+58.4%	0.844%
2/17/2021	Voloridge Investment Management LLC	10,091	$0.22M	0.0%	N/A	0.026%
2/16/2021	Orbimed Advisors LLC	350,000	$7.60M	0.1%	N/A	0.907%
2/16/2021	Silverarc Capital Management LLC	185,000	$4.02M	2.3%	N/A	0.479%
2/16/2021	HighVista Strategies LLC	63,053	$1.37M	0.9%	-2.5%	0.163%
2/16/2021	Endurant Capital Management LP	172,047	$3.74M	1.3%	-62.8%	0.446%
2/16/2021	Nuveen Asset Management LLC	264,323	$5.74M	0.0%	+141.5%	0.685%
2/16/2021	Price T Rowe Associates Inc. MD	20,968	$0.46M	0.0%	N/A	0.054%
2/16/2021	Engineers Gate Manager LP	19,486	$0.42M	0.0%	N/A	0.050%
2/16/2021	Avidity Partners Management LP	626,000	$13.59M	0.4%	N/A	1.622%
2/16/2021	Janus Henderson Group PLC	182,913	$3.96M	0.0%	+17.2%	0.474%
2/16/2021	ExodusPoint Capital Management LP	36,348	$0.79M	0.0%	N/A	0.094%
2/16/2021	Charles Schwab Investment Management Inc.	70,225	$1.53M	0.0%	+6.6%	0.182%
2/13/2021	American International Group Inc.	16,210	$0.35M	0.0%	+4.6%	0.042%
2/12/2021	Opaleye Management Inc.	322,200	$7M	0.9%	+120.7%	0.835%
2/12/2021	Federated Hermes Inc.	131,797	$2.86M	0.0%	N/A	0.341%
2/12/2021	The Manufacturers Life Insurance Company	17,228	$0.37M	0.0%	+16.6%	0.045%
2/12/2021	Ikarian Capital LLC	615,360	$13.36M	0.6%	+26.1%	1.594%
2/12/2021	Credit Suisse AG	28,787	$0.63M	0.0%	N/A	0.075%
2/12/2021	Kennedy Capital Management Inc.	150,283	$3.26M	0.1%	N/A	0.389%
2/12/2021	Virtus ETF Advisers LLC	13,576	$0.30M	0.1%	N/A	0.035%
2/11/2021	Northern Trust Corp	314,276	$6.82M	0.0%	+42.3%	0.814%
2/11/2021	Barclays PLC	230,119	$5M	0.0%	-3.8%	0.596%
2/11/2021	Citigroup Inc.	49,971	$1.09M	0.0%	+3,913.7%	0.129%
2/11/2021	Frazier Management LLC	1,001,421	$21.74M	1.7%	N/A	2.594%
2/11/2021	Asymmetry Capital Management L.P.	157,583	$3.42M	1.6%	N/A	0.408%
2/11/2021	Monashee Investment Management LLC	75,000	$1.63M	0.2%	N/A	0.194%
2/10/2021	Rhumbline Advisers	27,711	$0.60M	0.0%	+35.1%	0.072%
2/10/2021	Renaissance Technologies LLC	30,014	$0.65M	0.0%	N/A	0.078%
2/10/2021	Panagora Asset Management Inc.	65,452	$1.42M	0.0%	+60.3%	0.170%
2/9/2021	Wells Fargo & Company MN	62,746	$1.36M	0.0%	+37.3%	0.163%
2/9/2021	Bank of New York Mellon Corp	100,815	$2.19M	0.0%	+64.3%	0.261%
2/9/2021	ProShare Advisors LLC	12,137	$0.26M	0.0%	N/A	0.031%
2/8/2021	Alliancebernstein L.P.	15,900	$0.35M	0.0%	+24.2%	0.041%

Data available starting January 2016

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF. The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused primarily on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Today's Range

Now: $19.92

$19.46

$20.32

50 Day Range

MA: $19.36

$18.03

$21.35

52 Week Range

Now: $19.92

$7.06

$28.30

Volume

1,406,900 shs

Average Volume

497,755 shs

Market Capitalization

$918.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73

Who are the company insiders with the largest holdings of Sutro Biopharma?

Sutro Biopharma's top insider shareholders include:

William J Newell (CEO)
Trevor Hallam (Insider)
Arturo Md Molina (Insider)
John Gordon Freund (Director)

Who are the major institutional investors of Sutro Biopharma?

Sutro Biopharma's top institutional shareholders include:

BlackRock Inc. — 6.73%
Franklin Resources Inc. — 5.74%
First Light Asset Management LLC — 4.46%
Holocene Advisors LP — 3.09%
Loomis Sayles & Co. L P — 2.94%
Suvretta Capital Management LLC — 2.79%

Which institutional investors are selling Sutro Biopharma stock?

During the previous quarter, STRO stock was sold by these institutional investors:

BVF Inc. IL
Point72 Asset Management L.P.
Tekla Capital Management LLC
Pentwater Capital Management LP
Schonfeld Strategic Advisors LLC
Parkman Healthcare Partners LLC
Goldman Sachs Group Inc.
D. E. Shaw & Co. Inc.

During the last year, company insiders that have sold Sutro Biopharma company stock include:

William J Newell (CEO)
Trevor Hallam (Insider)

Which institutional investors are buying Sutro Biopharma stock?

In the previous quarter, STRO stock was bought by institutional investors including:

Loomis Sayles & Co. L P
First Light Asset Management LLC
Morgan Stanley
Franklin Resources Inc.
BlackRock Inc.
Holocene Advisors LP
Compagnie Lombard Odier SCmA
Dimensional Fund Advisors LP

In the previous year, these company insiders have bought Sutro Biopharma stock:

William J Newell (CEO)
Trevor Hallam (Insider)

Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom

From All Marijuana Stocks | Ad

With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.

Get All the Details on #1Interstate Cannabis